Developer docs
API playgroundTry for free, no card

Search company profiles

Canadian Cannabis Corp

Full company profile

uuid003l6e5

Namestring
Canadian Cannabis Corp
Legal namestring
Canadian Cannabis Corp
Websiteurl
canadiancannabiscorp.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBrampton, Canada
HQ citystring
Brampton
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical cannabis distribution, wholesale cannabis supply, pharmaceutical distribution, cannabis wholesale partnership, cannabis product distribution
Industry1 code
1Cannabis Wholesale Distribution (Flower, Extracts, Edibles)
CodeCRAOAIAFPrimaryYes
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Medical Cannabis Distribution
Social media profiles1 record
Cost components3 values
Supply Chain, Operations, Personnel
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Canadian Cannabis Corp partners with the world's largest wholesale distribution system for medical cannabis and pharmaceutical products. The company leverages this distribution relationship to supply medical cannabis to wholesale buyers across the pharmaceutical supply chain.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Medical Cannabis Wholesale Distribution
CategoryMedical Cannabis Distribution
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers9 records
1McKesson Corporation
TypeOthers
Description

The world's largest pharmaceutical distributor. Directly relevant because CCAN claims partnership with 'the world's largest wholesale distribution system for medical cannabis and pharmaceutical' — McKesson is the archetype of that channel.

2Aurora Cannabis
TypeBroad incumbent
Description

Major Canadian cannabis LP with a medical cannabis wholesale platform. Comparable as a large incumbent operating in the same regulated medical cannabis distribution channel.

3OrganiGram Holdings
TypeDirect peer
Description

Canadian LP focused on medical and recreational cannabis wholesale. Comparable peer in scale and product mix to what a wholesale-oriented Canadian cannabis company looks like operationally.

4AmerisourceBergen (Cencora)
TypeOthers
Description

Top-tier North American pharmaceutical wholesaler and distributor. Comparable as a reference point for the scale and operational model CCAN's described partnership implies.

5Canopy Growth Corporation
TypeBroad incumbent
Description

One of Canada's largest cannabis LPs with extensive medical and consumer wholesale channels. Comparable because it competes for the same Canadian wholesale distribution and pharmacy relationships CCAN targets.

6Shoppers Drug Mart (Loblaw Companies)
TypeRegional player
Description

Canada's largest pharmacy chain, which operates medical cannabis distribution through a partnership with multiple LPs. Relevant as a Canadian-specific wholesale/retail counterpart in medical cannabis supply.

7Hydropothecary (now Hexo Corp)
TypeDirect peer
Description

Canadian licensed producer of medical and adult-use cannabis. Directly comparable as a Canadian cannabis operator with wholesale ambitions; CCAN historically acquired Hydropothecary in 2015, making the two structurally linked peers.

8Novo Healthnet
TypeDirect peer
Description

Canadian health and medical services platform; CCAN acquired Novo Healthnet in 2015. Comparable as a peer in the Canadian medical/pharma services and distribution space.

9Tilray Brands
TypeBroad incumbent
Description

Global cannabis company with pharmaceutical-grade medical cannabis distribution. Relevant because it occupies the wholesale medical cannabis and pharma-adjacent positioning CCAN's claimed partnership suggests.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canadian Cannabis Corp

Medical Cannabis Distributioncanadiancannabiscorp.com

Canadian Cannabis Corp firmographics

Firmographics
Name
Canadian Cannabis Corp
Legal name
Canadian Cannabis Corp
Website
https://canadiancannabiscorp.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Canadian Cannabis Corp industry classification

Industry
Product category
Medical Cannabis Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)

Keywords

  • Medical cannabis distribution
  • Wholesale cannabis supply
  • Pharmaceutical distribution
  • Cannabis wholesale partnership
  • Cannabis product distribution

Where Canadian Cannabis Corp is headquartered

Location

Headquarters

HQ city
Brampton
HQ country
Canada
HQ region
North America

Markets served

Canadian Cannabis Corp business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel

Canadian Cannabis Corp product offering

Product offering

Core offering

Canadian Cannabis Corp partners with the world's largest wholesale distribution system for medical cannabis and pharmaceutical products. The company leverages this distribution relationship to supply medical cannabis to wholesale buyers across the pharmaceutical supply chain.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Wholesale Distribution

Companies that use Canadian Cannabis Corp

Customer profile

Ideal customer profiles1 record

Canadian Cannabis Corp technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Canadian Cannabis Corp partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights2 records

Canadian Cannabis Corp competitors and assessment

Company assessment

Others

  • McKesson Corporation: The world's largest pharmaceutical distributor. Directly relevant because CCAN claims partnership with 'the world's largest wholesale distribution system for medical cannabis and pharmaceutical' — McKesson is the archetype of that channel.
  • AmerisourceBergen (Cencora): Top-tier North American pharmaceutical wholesaler and distributor. Comparable as a reference point for the scale and operational model CCAN's described partnership implies.

Broad incumbents

  • Aurora Cannabis: Major Canadian cannabis LP with a medical cannabis wholesale platform. Comparable as a large incumbent operating in the same regulated medical cannabis distribution channel.
  • Canopy Growth Corporation: One of Canada's largest cannabis LPs with extensive medical and consumer wholesale channels. Comparable because it competes for the same Canadian wholesale distribution and pharmacy relationships CCAN targets.
  • Tilray Brands: Global cannabis company with pharmaceutical-grade medical cannabis distribution. Relevant because it occupies the wholesale medical cannabis and pharma-adjacent positioning CCAN's claimed partnership suggests.

Direct peers

  • OrganiGram Holdings: Canadian LP focused on medical and recreational cannabis wholesale. Comparable peer in scale and product mix to what a wholesale-oriented Canadian cannabis company looks like operationally.
  • Hydropothecary (now Hexo Corp): Canadian licensed producer of medical and adult-use cannabis. Directly comparable as a Canadian cannabis operator with wholesale ambitions; CCAN historically acquired Hydropothecary in 2015, making the two structurally linked peers.
  • Novo Healthnet: Canadian health and medical services platform; CCAN acquired Novo Healthnet in 2015. Comparable as a peer in the Canadian medical/pharma services and distribution space.

Regional players

  • Shoppers Drug Mart (Loblaw Companies): Canada's largest pharmacy chain, which operates medical cannabis distribution through a partnership with multiple LPs. Relevant as a Canadian-specific wholesale/retail counterpart in medical cannabis supply.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Canadian Cannabis Corp social profiles

Digital presence

Canadian Cannabis Corp financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canadian Cannabis Corp leadership team

Management profile

Number of profiles

Canadian Cannabis Corp funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canadian Cannabis Corp M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Cannabis Corp

What does Canadian Cannabis Corp do?

Canadian Cannabis Corp partners with the world's largest wholesale distribution system for medical cannabis and pharmaceutical products. The company leverages this distribution relationship to supply medical cannabis to wholesale buyers across the pharmaceutical supply chain.

When was Canadian Cannabis Corp founded?

Canadian Cannabis Corp was founded in 2014. It employs 1 to 10 people.

Where is Canadian Cannabis Corp based?

Canadian Cannabis Corp is headquartered in Brampton, Canada, in the North America region.

Who are Canadian Cannabis Corp's main competitors?

Others on record are McKesson Corporation and AmerisourceBergen (Cencora). Broad incumbents are Aurora Cannabis, Canopy Growth Corporation and Tilray Brands. Direct peers are OrganiGram Holdings, Hydropothecary (now Hexo Corp) and Novo Healthnet. Shoppers Drug Mart (Loblaw Companies) is listed as a regional player.

Does Canadian Cannabis Corp have an API?

No public API is recorded for Canadian Cannabis Corp.

What industry is Canadian Cannabis Corp in?

Canadian Cannabis Corp's product category is Medical Cannabis Distribution. Its primary akta.pro industry code is CRAOAIAF, Cannabis Wholesale Distribution (Flower, Extracts, Edibles). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comVillage Farms: President of Canadian cannabis sells $255k in VFF stock By Investing.comOrville Bovenschen, President of Canadian Cannabis at Village Farms International, sold 65,200 shares worth approximately $255,584 on December 1, 2025. Concurrently, Village Farms announced a $10 million share repurchase program and appointed Brian Ellis as its new Chief Information and Technology Officer. The company also reported that it was not awarded a conditional medical cannabis license in Texas during Phase I, though it plans to reapply in April 2026.GlobeNewswireSuccessful Overnight OfferingCanadian Life Companies Split Corp. completed its overnight offering of preferred and class A shares, led by National Bank Financial. Gross proceeds are expected to be about $40 million, with the offering closing on or about June 26, 2025. Net proceeds will invest in a portfolio of four Canadian life insurance companies.GlobeNewswireCanadian Cannabis Corp Announces the Receipt of a Statement of Allegations from the Ontario Securities CommissionCanadian Cannabis Corp received a Statement of Allegations from the Ontario Securities Commission alleging securities fraud between 2014 and 2016. The company and its current directors are studying the allegations and intend to cooperate fully with the Commission.The Washington PostThe buzz is true: Martha Stewart partners with Canadian cannabis company - The Washington PostMartha Stewart has announced a partnership with a Canadian cannabis company to create a line of gourmet cannabis edibles. This marks her entry into the cannabis market following her previous collaborations that drew significant public interest. Stewart's move highlights the growing acceptance and commercialization of cannabis products in the culinary field.GlobeNewswireCanadian Cannabis Corp Announces the Execution of a Revised Settlement Agreement For Sale of the Assets of The Clinic Network Inc.Canadian Cannabis Corp entered a revised settlement agreement to satisfy debts owed to creditors, assigning assets of its subsidiary The Clinic Network Inc. and depositing 1,750,000 Cura-Can Health Corp. shares in escrow. The company expects TCN to realize about CAD $250,000 in net proceeds and holds an option to buy up to 3,000,000 additional Cura-Can shares.GlobeNewswireCanadian Cannabis Corp Enters Settlement Agreement For Potential Sale of the Assets of The Clinic Network Inc.Canadian Cannabis Corp entered a settlement agreement to satisfy debts owed to creditors, assigning assets of its subsidiary The Clinic Network Inc. The agreement requires a successful financing for a Canadian entity, with an option for creditors to contribute CAD $1,500,000. Post-closing, the company expects approximately CAD $350,000 available, with CAD $270,000 held in escrow.GlobeNewswireCanadian Cannabis Corporation Expands Operations in Ontario-Set to Acquire Majority Stake in Hemisphere PharmaceuticalCanadian Cannabis Corporation executed a Letter of Intent to acquire a 60% stake in Hemisphere Pharmaceutical, a Brantford-based medical marijuana grower. The deal would give CCC access to HPI's proposed site near its Brampton facility, with plans to close by April 1, 2015. Both companies are seeking Health Canada licensing.GlobeNewswireCORRECTION FROM SOURCE: Canadian Cannabis Corp. Appoints Richard Wachsberg as Independent DirectorCanadian Cannabis Corp. appointed Richard Wachsberg as independent director on Jan. 15, 2015. Wachsberg is co-founder and chairman of Apollo Health and Beauty Care, a personal care manufacturer. The company expects him to support its corporate governance and medical marijuana initiatives.GlobeNewswireCanadian Cannabis Corp. Appoints Richard Wachsberg as Independent DirectorCanadian Cannabis Corp. has appointed Richard Wachsberg, co-founder and Chairman of Apollo Health and Beauty Care, as an independent director. CEO Benjamin Ward stated that the company welcomes Wachsberg's experience in corporate governance and his support for the potential health care contributions of medical marijuana. The announcement includes standard forward-looking statement disclaimers regarding market conditions and competitive factors.GlobeNewswireCanadian Cannabis Corp. to Acquire Controlling Interest in Novo HealthnetCanadian Cannabis Corp. entered a Letter of Intent to acquire a 61% controlling interest in Novo HealthNet for 2 million of its own shares, valued at approximately $9.6 million USD. The deal, expected to close on February 12, 2015, includes Novo's 45 clinics and its preferred provider status. The company also applied to Health Canada to become a medical marijuana producer.